| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.0086 | 1 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | 0.0085 | 1 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |